Table 6.
Gene | Tumors | Prostate | Kidney | Testis | Immune Disease |
---|---|---|---|---|---|
CCR2 | ○ | ○ | ○ | ○ | |
LRRN3 | ○ | ○ | |||
AHR | ○ | ○ | ○ | ○ | ○ |
LOX | ○ | ○ | ○ | ○ | ○ |
PRAMEL1 | ○ | ○ | ○ | ||
CD53 | ○ | ○ | ○ | ||
ITGAL (CD11A) | ○ | ○ | ○ | ○ | ○ |
SULT1C2 | ○ | ||||
FCGR2B | ○ | ○ | |||
ELOVL2 | ○ | ||||
PF4 (CXCL4) | ○ | ○ | ○ | ○ | |
PDHA2 | ○ | ||||
MPO | ○ | ○ | ○ | ○ | ○ |
HAND2 | ○ | ||||
CCL3 | ○ | ○ | ○ | ○ | |
CMKLR1 (CHEMR23) | ○ | ○ | ○ | ||
DBH | ○ | ○ | ○ | ○ | ○ |
KCNT1 | ○ | ||||
FGB | ○ | ○ | ○ | ○ | |
BMP3 | ○ | ○ | ○ | ||
ACTG2 | ○ | ||||
AQP2 | ○ | ○ | ○ |
Circles indicate that there was at least one study reporting a relationship between identified gene and disease. For related references, see additional file 1. Genes that were reported to be related to tumor, prostate, kidney, testis and immune diseases are listed.